FDA, FTC take aim at abuse of restricted drug programs
Last year, generic drugmakers filed 150 complaints with the Food and Drug Administration that branded drug manufacturers were misusing the agency’s regulations to block them from offering cheaper alternatives for some...To view the full article, register now.
Already a subscriber? Click here to view full article